AKBA NASDAQ
Akebia Therapeutics, Inc.
1W: -3.5%
1M: -11.8%
3M: -33.5%
YTD: -44.2%
1Y: -67.7%
3Y: -24.8%
5Y: -69.8%
$0.86
-0.01 (-0.69%)
Weekly Expected Move ±7.9%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$219M
Revenue
+7.5% YoY
$-30M
Net Income
+18.7% YoY
$40M
Free Cash Flow
+1677.2% YoY
78.8%
Gross Margin
-12.9%
Op. Margin
-18.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-109.4%
ROA-8.5%
ROIC15.6%
Valuation
P/E-8.0
P/B9.3
EV/EBITDA-11.4
Leverage
Debt/Equity2.16
Current Ratio1.43
Interest Cov.-2.5x
Quality Scores
Piotroski F6/9
Altman Z-5.57
Beneish M-3.67